Learn what tirzepatide is, what a clinician may consider during a telehealth evaluation, and how to prepare for an informed conversation about medical weight-management options.
Tirzepatide is a prescription medication that acts on GIP and GLP-1 pathways. These hormone pathways are involved in appetite and blood sugar regulation. Specific FDA-approved uses depend on the product and dose; a clinician can help explain which questions are relevant to your health history.
Tirzepatide acts on GIP and GLP-1 receptor pathways. That general mechanism does not determine whether a medication is appropriate, safe, available, or covered for one person.
A medication name alone is not a treatment plan. The evaluation focuses on your individual health context.
Your clinician may review your current medications, prior treatment, relevant health history, goals, and questions.
Tirzepatide may be discussed along with other medical weight-management options when clinically appropriate.
The clinician may discuss potential risks, benefits, alternatives, labs, follow-up, or whether in-person care is needed.
The Initial GLP-1 Evaluation is $100. Medication, pharmacy, laboratory, delivery, refill, and future-visit costs are separate unless explicitly stated.
Understand GLP-1 consultation costs ->Care is subject to clinical evaluation. A clinician may recommend a different option, additional information or testing, follow-up, or in-person care instead of prescribing medication.
Review GLP-1 labs and eligibility questions ->Explore how Kosius approaches GLP-1 weight management, including a clinician-led evaluation and questions to ask before treatment decisions are made.
Read the GLP-1 weight management guide ->Tirzepatide is a prescription medication that acts on GIP and GLP-1 receptor pathways, which are involved in appetite and blood sugar regulation. Specific FDA-approved uses depend on the product and dose, and a clinician can explain which questions are relevant to your situation.
Tirzepatide acts on both GIP and GLP-1 receptor pathways. That difference alone does not determine whether it is appropriate for a particular patient. A clinician considers your individual health history, medications, risks, and goals.
Yes. A Georgia-licensed clinician may discuss tirzepatide during a scheduled telehealth evaluation when you are physically located in Georgia. Care is subject to clinical evaluation, and prescriptions are not guaranteed.
No prescription is guaranteed. The clinician will review your health history, goals, current medications, risks, and possible next steps before making an individual treatment decision.
No. The $100 fee is for the Initial GLP-1 Evaluation. Medication, pharmacy, laboratory, delivery, refill, and future-visit costs are separate unless explicitly stated.
Some patients may need laboratory work or other information before a treatment decision. Your clinician will discuss what may be appropriate for your situation.
Book a scheduled virtual evaluation while physically located in Georgia.
Book Initial GLP-1 Evaluation
